ImmuCell
ICCC
25 hedge funds and large institutions have $5.39M invested in ImmuCell in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 3 closing their positions.
2% more capital invested
Capital invested by funds: $5.31M → $5.39M (+$83.5K)
0.32% less ownership
Funds ownership: 13.45% → 13.13% (-0.32%)
11% less funds holding
Funds holding: 28 → 25 (-3)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.1K |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$30.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15.2K |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
+$515 |
| 5 |
JP Morgan Chase
New York
|
+$21 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$102K |
| 2 |
MWM
Mission Wealth Management
Santa Barbara,
California
|
-$50.9K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$43.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$13.7K |
| 5 |
Renaissance Technologies
New York
|
-$6.7K |
ICCC Hedge Fund Activity: Q1 2024 in Review
25 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2024, worth a combined $5.39M — up 1.6% from $5.31M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ICCC and 0 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 6 added.
The largest buyer was Vanguard Group, adding an estimated $50.1K. The largest seller was Morgan Stanley, cutting an estimated $102K.
- 25 institutional investors held ImmuCell (ICCC) as of Q1 2024, down from 28 in Q4 2023.
- Funds reported $5.39M of ImmuCell stock for Q1 2024, up 1.6% quarter-over-quarter.
- 0 funds opened new ImmuCell positions in Q1 2024 and 3 closed out, a net change of -3 holders.
- The largest ImmuCell buyer in Q1 2024 was Vanguard Group, an estimated $50.1K added.
- The largest ImmuCell seller in Q1 2024 was Morgan Stanley, an estimated $102K sold.
Based on aggregated 13F filings for Q1 2024.